GROWTH AND INCOME: Johnson & Johnson
Market cap billions: $183.6
P/E ratio*: 16
Earnings growth**: 9%
Dividend yield: 2.7%
Johnson & Johnson is far more diversified than most pharmaceutical companies, selling everything from Band-Aid bandages to Tylenol painkillers. We like it because the company's dividend has grown at a rate of 14% over the past five years.
And during its last quarter, earnings jumped 9% on strong domestic and overseas sales. Among the top-performing brands were Listerine mouthwash and Zyrtec, an over-the-counter allergy medicine.
NEXT: GROWTH AND INCOME: Procter & Gamble
-
Abbott Labs -
Coca-Cola -
Colgate-P... -
General M... -
Illinois ... -
Johnson &... -
Procter &... -
US Bancorp -
Accenture -
Chubb -
Cisco Sys... -
McKesson -
3M -
Microsoft -
Parker Ha... -
Walgreen -
Applied I... -
Carlisle ... -
Cascade -
National ... -
Pfizer -
Regal Bel... -
UST -
VF Corp. -
Adtran -
AVX -
Fair Isaac -
Global In... -
Grey Wolf -
Penn Virg... -
Plexus -
Tessera T... -
BP -
Diageo -
Novartis -
Philips E... -
Sanofi-Av... -
Total -
Unilever -
Vodafone ...
Last updated June 20 2008: 2:35 PM ET
RSS Criteria include long-term earnings growth equal to or greater than the S&P 500's estimated 7% rate, dividend yield greater than the S&P 500's 2%, and P/E ratios below 27.
*Based on previous 12-months' reported earnings.
**Wall Street estimates for the next three to five years.
Source: Zacks Investment Research
*Based on previous 12-months' reported earnings.
**Wall Street estimates for the next three to five years.
Source: Zacks Investment Research
